In episode 510, Mike and James talk about a trial that looks at what happens when you discontinue antidepressants in primary care. We see there is about a 15% absolute difference in the chance of relapse – and we put all this into context because this is a PREMIUM podcast. We also discuss what happens…

In episode 509, James, Mike and Tina finish talking about our new clinical practice guideline on chronic pain. We focus on the top questions we all have in chronic pain and also discuss the best available evidence for the many different medications we use for chronic pain.

Show Notes

1. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care
2. Guideline summary
3. Patient Handout
4. PEER pain calculator
5. Tame the Beast

In episode 508, James and Mike ask Tina to come in and talk about our new clinical practice guideline on chronic pain. We focus on the best available evidence which shows that physical activity is key (except for neuropathic pain). We also go over the role for psychological interventions and the problem with opioids.

Show Notes

1. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care
2. Guideline summary
3. Patient Handout
4. PEER pain calculator

In episode 507, James and Mike and Adrienne continue the discussion about our new clinical practice guideline on pain. We discuss the evidence for the treatments used for back pain and neuropathic pain and give you all the numbers and the nuances.

 Show Notes

1. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care
2. PEER pain calculator

In episode 506, James and Mike invite Adrienne Lindblad to discuss our latest clinical practice guideline on the management of chronic low back, osteoarthritic, and neuropathic pain in primary care. In this episode we describe the development process and then highlight the best available evidence, including both benefits and harms, for chronic osteoarthritis treatments. We talk about the other chronic pain topics in episode 507 so keep listening.

Show Notes

1. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care
   Canadian Family Physician March 2022, 68 (3) 179-190
2. PEER pain calculator

In episode 505, James and Mike invite nephrologists Samira Farouk and Matthew Sparks to discuss the tricky issue of albuminuria – who to monitor, what to monitor and who to treat. We spend a lot of time dribbling and end up deciding that nothing is a slam dunk, so stay until the end for a real buzzer beater.

Show Notes

1) ACR variability

AJKD 2013;62:1095–1101

2) Kidney Failure Risk Equation

3) Albumin Handout

4) American Journal of Kidney Disease Blog

5) NephMadness 

6) May 27/28. 2022 The MEME conference – Making Evidence Matter For Everyone

In episode 504, James and Mike invite Jen Potter back to the podcast to talk about whether or not intrauterine devices for preventing pregnancy can be used beyond the recommended duration of use. It seems one can defer IUD replacement for at least up to 12 months. Have a listen and see what you think.

Show Notes

1) Tools for Practice
Can It Stay or Must It Go? Extended Use of Intrauterine Devices

2) The Aural Apothecary Podcast – check it out

3) The MEME Conference – Make Evidence Matter for Everyone

4) CFPC Learn – Continuing Professional Development made by and for family physicians

In episode 503, James and Mike explore the evidence around water for a variety of different health outcomes. How much do we need and does it matter where we get it from? The only thing we know is that 8 glasses a day is wrong.

Show Notes

Coming soon

In episode 502, James, Mike Kolber and Tony Nickonchuk get together to talk about the easy question (just kidding) of COVID vaccines for children and adolescents. We discuss the best evidence we could find around efficacy and adverse effects in these age groups and hopefully give enough context so that you go from murky to somewhat less cloudy as to what we know and don’t know about this topic.

Show Notes

1) Tools for Practice
CO-KID: Covid vaccine for kids

2) Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
January 12, 2022 DOI: 10.1056/NEJMoa2117995

3) Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

4) Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

In episode 501, Mike and James get back to being PREMIUM by talking about the impressive effect of Kangaroo care – listen to find out what that is. We also talk about the problem with guidelines around Vitamin D and yet again more evidence for delayed antibiotics.

Show Notes

1) Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
Cochrane Database Syst Rev 2016 Aug 23;2016(8):CD002771
2) Immediate “Kangaroo Mother Care” and Survival of Infants with Low Birth Weight
N Engl J Med 2021;384:2028-38
3) Vitamin D recommendations in clinical guidelines: A systematic review, quality evaluation and analysis of potential predictors
Int J Clin Pract. 2021 Nov;75(11):e14805. doi: 10.1111/ijcp.14805. Epub 2021 Sep 15
4) Delayed Antibiotic Prescription for Children With Respiratory Infections: A Randomized Trial
Pediatrics. 2021 Mar;147(3):e20201323. doi: 10.1542/peds.2020-1323. Epub 2021 Feb 11.
5) Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis
BMJ 2021;373:n808